Edgar Engelman, M.d.

Biography

 Dr. Engleman is a Professor of Pathology and Medicine at Stanford University School of Medicine, where he oversees the Stanford Blood Center. His research has primarily focused on the interactions between cancer and the immune system. A former editor of numerous scientific journals and the inventor of multiple patented technologies, Dr. Engleman has authored more than 280 publications in medical and scientific journals and has trained more than 200 graduate students and postdoctoral fellows. He is a co-founder of Vivo Capital, LLC, and a scientific founder of a number of biopharmaceutical companies including Dendreon. Dr. Engleman received his A.B. from Harvard University and his M.D. from Columbia University School of Medicine.

Research Interest

Pathology and Medicine